Skip to content

Lynnette A. Averill

31 papers in the library · 645 citations · publishing 2015-2026

Papers

Sort Most recent Most cited

The Neurobiology and Pharmacotherapy of Posttraumatic Stress Disorder.

The Annual Review of Pharmacology and Toxicology September 14, 2018 Chadi G. Abdallah, Lynnette A. Averill, Teddy J. Akiki et al.

New approaches to the neurobiology of posttraumatic stress disorder (PTSD) are needed to address the reported crisis in PTSD drug development. These new approaches may require the field to move beyond a narrow fear-based perspective, as fear-based medications have not yet demonstrated compelling efficacy. Antidepressants, particularly recent rapid-acting antidepressants, exert complex effects...

The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects.

Neuropsychopharmacology September 2018 Chadi G. Abdallah, Henk M De Feyter, Lynnette A. Averill et al.

The ability of ketamine administration to activate prefrontal glutamate neurotransmission is thought to be a key mechanism contributing to its transient psychotomimetic effects and its delayed and sustained antidepressant effects. Rodent studies employing carbon-13 magnetic resonance spectroscopy (13C MRS) methods have shown ketamine and other N-methyl-D-aspartate (NMDA) receptor antagonists to...

Ketamine, but Not the NMDAR Antagonist Lanicemine, Increases Prefrontal Global Connectivity in Depressed Patients.

Chronic Stress 2018 Chadi G. Abdallah, Arpan Dutta, Christopher L. Averill et al.

Identifying the neural correlates of ketamine treatment may facilitate and expedite the development of novel, robust, and safe rapid-acting antidepressants. Prefrontal cortex (PFC) global brain connectivity with global signal regression (GBCr) was recently identified as a putative biomarker of major depressive disorder (MDD). Accumulating evidence have repeatedly shown reduced PFC GBCr in MDD,...

Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment.

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging October 2017 Chadi G. Abdallah, Christopher L. Averill, Ramiro Salas et al.

Prefrontal global brain connectivity with global signal regression (GBCr) was proposed as a robust biomarker of depression, and was associated with ketamine's mechanism of action. Here, we investigated prefrontal GBCr in treatment-resistant depression (TRD) at baseline and following treatment. Then, we conducted a set of pharmacological challenges in healthy subjects to investigate the...

DOI: 10.1016/j.bpsc.2017.04.006 (opens in new tab) Full text (opens in new tab) Ketamine Treatment resistant depression Functional MRI Global brain connectivity +2

Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine as a Prototype Novel Therapeutic

Current Psychiatry Reports August 26, 2017 J. Krystal, Chadi G. Abdallah, Lynnette A. Averill et al.

Purpose of ReviewStudies of the neurobiology and treatment of PTSD have highlighted many aspects of the pathophysiology of this disorder that might be relevant to treatment. The purpose of this review is to highlight the potential clinical importance of an often-neglected consequence of stress models in animals that may be relevant to PTSD: the stress-related loss of synaptic...

Ketamine as a promising prototype for a new generation of rapid‐acting antidepressants

Annals of the New York Academy of Sciences February 27, 2015 Chadi G. Abdallah, Lynnette A. Averill, John H. Krystal 117 citations

The discovery of ketamine's rapid and robust antidepressant effects opened a window into a new generation of antidepressants. Multiple controlled trials and open-label studies have demonstrated these effects across a variety of patient populations known to often achieve little to no response from traditional antidepressants. Ketamine has been generally well tolerated across patient groups, with...